Centre Léon Bérard;Netris Pharma;Centre National de la Recherche Scientifique;Université Claude Bernard Lyon 1
发明人:
申请号:
EP13763033.1
公开号:
EP2895173B1
申请日:
2013.09.12
申请国别(地区):
EP
年份:
2018
代理人:
摘要:
Pharmaceutical composition comprising a chemotherapeutic drug and a netrin-1 interfering drug or a vector capable of expressing a netrin-1 interfering drug in vivo, in a pharmaceutically acceptable carrier or vehicle. The chemotherapeutic drug is selected from those able to induce over expression of netrin-1 in cancer cells. The combination is associated with synergic anti-cancer effect.